Caitlin John, LLC Pacira Bio Sciences, Inc. Transaction History
Caitlin John, LLC
- $151 Billion
- Q4 2024
A detailed history of Caitlin John, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Caitlin John, LLC holds 1,872 shares of PCRX stock, worth $43,748. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,872
Previous 96
1850.0%
Holding current value
$43,748
Previous $1.58 Million
2133.57%
% of portfolio
0.02%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$187 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$123 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$76.3 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$52.8 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$46.6 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.07B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...